|
13. INCOME TAXES (Details-Income tax provision) (USD $)
|
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
|
| Income Tax Disclosure [Abstract] | ||
| Income tax benefit at statutory rate | $ (444,442)us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | $ (782,067)us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate |
| State taxes | (94,475)us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes | (132,094)us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes |
| Stock-based compensation | 2,293,891us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | 0us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost |
| Investment in KannaLife Sciences | (2,567,000)us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary | 0us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary |
| Amortization of discount on convertible note | 200,421us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization | 3,880us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization |
| Permanent differences | (8,114)us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther | 0us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther |
| Other | 69,948us-gaap_IncomeTaxReconciliationOtherAdjustments | 0us-gaap_IncomeTaxReconciliationOtherAdjustments |
| Change in valuation allowance | 549,771us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | 910,281us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance |
| Tax provision | $ 0us-gaap_IncomeTaxExpenseBenefit | $ 0us-gaap_IncomeTaxExpenseBenefit |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible amortization. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible equity-based compensation costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|